Key facts
- It has raised $11.3M across 2 recorded rounds; the latest was Seed Round ($1.8M) in Jul 2025.
- Notable investors include Conconi Growth Partners, Break Off Capital, CME Ventures, Hilltop Venture Partners, Tribune Capital (Asset Management).
- Synthesis Health has filed 2 Form Ds with the SEC since 2024, most recently Aug 2025 ($1.8M sold to 14 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Synthesis Health
Funding rounds
2 roundsAbout Synthesis Health
Developer of an AI-enabled cloud informatics platform designed to streamline medical imaging workflows and enhance diagnostic efficiency. The company offers workflow management, automated exam assignment, clinical and AI-generated reporting, image management, peer review, critical results tracking, management reporting, cloud storage, and back-up reading capabilities, enabling hospitals, imaging centers, radiology groups, and OEMs to improve clinical productivity and operational accuracy.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Maple Ridge, Canada
- Founded
- 2022
- Employees
- 100
- Website
- synthesis.health/
- Ownership
- Privately Held (backing)
Synthesis Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Synthesis Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Synthesis Health in its N-PORT filings yet. We sweep new filings monthly.